Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese
SGLT2 inhibitor from a clinical research perspective: boundary-breaking pioneer in the treatment of diabetic heart failure
Ling CHEN, Zhongqun WANG
Chinese Journal of Clinical Pharmacology and Therapeutics . 2026, (6): 722 -728 .  DOI: 10.12092/j.issn.1009-2501.2026.06.001